Table 4.
Adverse events of trastuzumab-pkrb + GemCis.
| Adverse Events | Any Grade | Grade 3 |
|---|---|---|
| Any adverse events | 4 (100%) | 4 (100%) |
| Haematologic | ||
| Leukopenia | 4 (100%) | 0 (0.0%) |
| Neutropenia | 4 (100%) | 3 (75.0%) |
| Anaemia | 4 (100%) | 1 (25.0%) |
| Thrombocytopenia | 1 (25.0%) | 0 (0.0%) |
| Febrile neutropenia | 0 (0.0%) | 0 (0.0%) |
| Non-haematologic | ||
| Anorexia | 2 (50.0%) | 0 (0.0%) |
| Nausea | 2 (50.0%) | 1 (25.0%) |
| Fatigue | 1 (25.0%) | 0 (0.0%) |
| Fever | 1 (25.0%) | 0 (0.0%) |
| Tremor | 1 (25.0%) | 1 (25.0%) |
| Allergic reaction | 2 (50.0%) | 0 (0.0%) |
| Hypoalbuminemia | 2 (50.0%) | 0 (0.0%) |
| Increased AST | 1 (25.0%) | 0 (0.0%) |
| Increased ALT | 1 (25.0%) | 0 (0.0%) |
| Increased ALP | 2 (50.0%) | 0 (0.0%) |
| Increased bilirubin | 1 (25.0%) | 1 (25.0%) |
Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase.